Syndicates are single-deal VC funds that let you invest deal-by-deal in specific startups. The syndicate forms a Special Purpose Vehicle (SPV) to make that single investment. For the 1855 Capital syndicate, 1855 acts as the general partners sourcing the investments, conducting due diligence, and securing allocations.
When an 1855 Capital approves your request to join their Syndicate, you gain access to their current and future deal flow and can pick investments on a deal-by-deal basis. Syndicate leads share details on the opportunity with syndicate investors, and investors sign documents online and fund investments via ACH or wire.
The minimum investment size is between $1K and $10K per deal.
Deals in the syndicate are only visible to those in the fund, such as founders/leads, and other investors who are invited into the fund. Leads can decide what information is accessible to investors, or limit information to only those investors who are under NDA.
Our offices are located in State College, PA, which allows us to stay closely connected to University Park’s innovation ecosystem as well as the research and start-up activity across Penn State’s 19 Commonwealth Campuses.
We expect that a many of our investments will emerge from the central Pennsylvania region, especially from transformative research at Penn State’s University Park campus and significant human health and treatment breakthroughs from Penn State Milton S. Hershey Medical Center.
Our mission, however, is to be an early capital source for all Penn State-related startups and we identify and work with teams at Penn State campuses across the Commonwealth. We do, however, emphasize the central Pennsylvania campuses at:
All these areas are underserved by capital sources from Philadelphia, Pittsburgh and Lehigh Valley and can especially benefit from our close working relationship with Ben Franklin Technology Partners of Central Pennsylvania.
We look for companies that:
Though we expect to be early or even the first equity investors in a team, we are interested in being a co-investor with other early stage venture funds.